Farzan Kianersi, Rezaei Leila, Ghanbari Heshmatollah, Dehghani Alireza
Department of Ophthalmology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Saudi J Kidney Dis Transpl. 2014 May;25(3):615-20. doi: 10.4103/1319-2442.132208.
A lesser known complication of long-term corticosteroid therapy is chronic central serous chorioretinopathy (CSCR). Although idiopathic CSCR is known to be mild with spontaneous improvement and minimal effects on the vision, chronic CSCR is different and may cause irreversible visual loss. We report four patients with CSCR on corticosteroid therapy after kidney transplant. The interesting point about these patients is that they were of a younger age group compared with classic CSCR cases, and there were two females among the patients. Organ transplantation and corticosteroid therapy are the risk factors for CSCR. We should discontinue or at least reduce corticosteroid dosage. Knowledge about this rare complication after kidney transplantation (even in unusual age and sex) is important.
长期使用皮质类固醇疗法的一种鲜为人知的并发症是慢性中心性浆液性脉络膜视网膜病变(CSCR)。虽然已知特发性CSCR症状较轻,可自发改善且对视力影响极小,但慢性CSCR则不同,可能导致不可逆的视力丧失。我们报告了4例肾移植后接受皮质类固醇治疗而发生CSCR的患者。这些患者的有趣之处在于,与典型的CSCR病例相比,他们年龄较轻,且其中有两名女性。器官移植和皮质类固醇治疗是CSCR的危险因素。我们应停用或至少减少皮质类固醇剂量。了解肾移植后这种罕见并发症(即使在不寻常的年龄和性别中出现)很重要。